ERNA Eterna Therapeutics
- 0.996
- +0.020+2.06%
- 0.970
- -0.026-2.62%
Eterna Therapeutics News
Eterna Therapeutics Strikes Key Deal for Disease-Fighting Tech
Express News | Eterna Therapeutics Inc: On Sept 24 Co Entered Into License & Collaboration Agreement Effective Sept 9, 2024, With Factor Bioscience Limited
Eterna Therapeutics | 10-Q: Q2 2024 Earnings Report
12 Health Care Stocks Moving In Monday's Intraday Session
10-Q: Q1 2024 Earnings Report
Express News | Eterna Therapeutics Announces Appointment of Mahendra Rao, Phd, to Its Scientific Advisory Board
Eterna Therapeutics Announces Appointment of Mahendra Rao, PhD, to Its Scientific Advisory Board
Press Release: Eterna Therapeutics Announces Appointment of Mahendra Rao, PhD, to Its Scientific Advisory Board
Eterna Therapeutics to Present at the ASGCT 27th Annual Meeting on Development of Beta 2 Microglobulin-Knockout (B2M-KO) IMSC Line With Enhanced Immunosuppressive Activity and Stealthing Features That May Further Augment the Therapeutic Potential of...
Factor Bioscience Expands Translational Science Team, Appoints Kyle Garland, Ph.D., as Director of Translational Science
Earnings Week Ahead: Walgreens Boots Alliance, Carnival, GameStop and More
Express News | Eterna Therapeutics Inc On March 19, Received A Notice From Nasdaq Stating That Co Is Not In Compliance With Nasdaq Listing Rule 5550(B)(1)
Press Release: Eterna Therapeutics Announces the Appointment of Peter Cicala, JD, to Its Board of Directors
Eterna Therapeutics Welcomes New Board Member Peter Cicala
12 Health Care Stocks Moving In Friday's Pre-Market Session
Eterna Therapeutics Files to Sell 18.2M Shares for Holders
Eterna Therapeutics Grants New President and CEO Sanjeev Luther Inducement Award Under Nasdaq Listing Rule 5635 (C)(4)
Eterna Therapeutics Appoints Sanjeev Luther as President and CEO
Eterna Therapeutics Names Sanjeev Luther as President and Chief Executive Officer
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Analysis
Price Target
No Data
No Data